Surprise Billing, Drug Pricing & Extenders Deferred To May 22

By Ariel Cohen , John Wilkerson  / December 16, 2019 at 2:34 PM
Updated Story Congress is creating a new opening to vote on surprise billing and drug pricing legislation next May by limiting Medicare and Medicaid extenders to five months in a year-long government funding bill. Lawmakers released a funding deal on Monday night (Dec. 16), and neither surprise billing nor drug pricing legislation are included. The so-called extenders, a package of Medicare and Medicaid policies, are included in the appropriations bill, but they’ll run for only five months...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.